An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)

NCT ID: NCT06576323

Last Updated: 2025-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-01

Study Completion Date

2026-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to address the gap in maternal OUD treatment and infant neonatal opioid withdrawal syndrome care. The research team will develop a treatment model and a set of strategies to provide evidence-based OUD treatment to postpartum mothers in NICUs.

First, the investigators will conduct a needs assessment via in-depth qualitative interviews with NICU mothers and clinicians. Then, with the expertise of the advisory board, the the researchers will create a protocol for implementing maternal OUD treatment at the NICU bedside. The researchers will then implement the protocol in two partner NICUs and evaluate the acceptability and feasibility to patients, providers, and clinical, and administrative leaders.

The goal of this research study is to integrate maternal mental health and substance abuse treatment in pediatric settings and to refine, test, and examine the acceptability and feasibility of applying the adapted model.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The increasing prevalence of pregnant and postpartum women affected by Opioid Use Disorder (OUD) in the US is highlighted by the growing number of babies referred to the NICU for Neonatal Abstinence Syndrome after birth. Despite recent advances in integrating mental health and substance abuse treatment into adult healthcare settings, no current treatment options exist to integrate maternal OUD treatment and referrals into the pediatric care setting making it unlikely that mothers will be able to access care. In order to preserve the dyadic bond, improve maternal functioning, and provide a more stable environment for the infant after discharge from the NICU, the researchers now embark on a study utilizing steps from intervention mapping to identify facilitators and barriers to integrated maternal OUD treatment and referral in the NICU, adapt existing evidence-based models of co-located OUD care to the NICU setting, and test the feasibility and acceptability of the new model. In Aim 1, the researchers will collect qualitative data via in-depth interviews with 32 NICU providers, social workers, administrators, and parents to determine barriers and facilitators to offering bedside buprenorphine induction and treatment. In Aim 2, the researchers will convene an advisory board to review data collected in Aim 1 and to develop a plan for implementing buprenorphine initiation into the study's unique setting to address the issue- the provision of adult focused OUD care in a pediatric care setting. Aim 2 does not constitute Human Subjects research. The primary outcome of Aim 2 will be a suite of implementation strategies to pilot test in Aim 3. Aim 3 is a pilot case series implementation trial where the researchers will test the adapted intervention to determine feasibility and acceptability to both providers and patients. As this is a case series the investigators propose to recruit 10 participants from each of the two partner NICUs for a total enrollment of N= 20 in Aim 3. A formal sample size calculation was not performed as there is no data on which to a base a formal sample size calculation. For pilot studies with an expected medium standardized effect size, a case number of N= 15 per group has been recommended for pilot studies preceding a possible main study with a power of 90%. The investigators plan to recruit 20 participants to account for possible attrition. The researchers are not necessarily powered to detect an effect. Participants will not be randomized to condition; all NICU mothers meeting inclusion criteria during the study timeline for Aim 3 will be invited to participate in Aim 3. The outcomes of acceptability and feasibility will be measured through questionnaires, interviews, and treatment initiation and retention statistics.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid Use Disorder Neonatal Abstinence Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Case Series

In Aim 3, all recruited participants will receive the intervention.

Group Type OTHER

An implementation model for co-located Medications for Opioid Use Disorder (MOUD) prescription in the NICU

Intervention Type BEHAVIORAL

We will use implementation mapping to develop a suite of implementation strategies to deliver evidence-based MOUD prescription to mothers attending the bedside of their infants hospitalized in the NICU. The intervention itself is buprenorphine induction and treatment, however the model for delivery is not yet developed, consistent with the need for results from Aim 1 to inform the approach used to develop the implementation model in Aim 2.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

An implementation model for co-located Medications for Opioid Use Disorder (MOUD) prescription in the NICU

We will use implementation mapping to develop a suite of implementation strategies to deliver evidence-based MOUD prescription to mothers attending the bedside of their infants hospitalized in the NICU. The intervention itself is buprenorphine induction and treatment, however the model for delivery is not yet developed, consistent with the need for results from Aim 1 to inform the approach used to develop the implementation model in Aim 2.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants should be healthcare providers working within UPHS, who generally treat perinatal women or any individuals with OUD; for the purposes of this study, provider refers to a Medical Doctor (MD) or Doctor of Osteopathy (DO), Advanced Practice Practitioner, Nurse, or Social Worker.
* Participants should provide direct care to NICU patients and/or their mothers
* Participants should be proficient in English language
* Participants should have access to a computer with internet connectivity or phone


* Participants should be biological mothers of children hospitalized in the UPHS NICU for NAS
* Participants should be diagnosed with opioid use disorder


* We will use this same criteria to recruit new participants for Aim 3 if the same stakeholder interviewees are unavailable at the time of Aim 3.


* Participants should be biological mothers of a child hospitalized in either of the two UPHS NICU for NAS (either HUP or PAH)
* Participants should be no more than 4 weeks postpartum
* Participants should have an Opioid Use Disorder than is currently untreated with medication assisted treatment or buprenorphine

Exclusion Criteria

\- None


\- None


\- None


\- Active suicidal ideation, or other severe psychopathology that must be addressed before effective MOUD can be prescribed
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Pennsylvania

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sara Kornfield, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status RECRUITING

Penn Center for Women's Behavioral Wellness

Philadelphia, Pennsylvania, United States

Site Status RECRUITING

Pennsylvania Hospital

Philadelphia, Pennsylvania, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sara Kornfield, PhD

Role: CONTACT

215-746-1255

Emma Farber, BA

Role: CONTACT

215-746-3338

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sara Kornfield, PhD

Role: primary

215-746-1255

References

Explore related publications, articles, or registry entries linked to this study.

Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017. JAMA. 2021 Jan 12;325(2):146-155. doi: 10.1001/jama.2020.24991.

Reference Type BACKGROUND
PMID: 33433576 (View on PubMed)

Winkelman TNA, Villapiano N, Kozhimannil KB, Davis MM, Patrick SW. Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004-2014. Pediatrics. 2018 Apr;141(4):e20173520. doi: 10.1542/peds.2017-3520.

Reference Type BACKGROUND
PMID: 29572288 (View on PubMed)

Ray-Griffith S, Tharp E, Coker JL, Catlin D, Knight B, Stowe ZN. Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention. Am J Addict. 2021 Jan;30(1):43-48. doi: 10.1111/ajad.13084. Epub 2020 Jul 16.

Reference Type BACKGROUND
PMID: 32673447 (View on PubMed)

Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009 Aug 7;4:50. doi: 10.1186/1748-5908-4-50.

Reference Type BACKGROUND
PMID: 19664226 (View on PubMed)

Becker-Haimes EM, Mandell DS, Fishman J, Williams NJ, Wolk CB, Wislocki K, Reich D, Schaechter T, Brady M, Maples NJ, Creed TA. Assessing Causal Pathways and Targets of Implementation Variability for EBP use (Project ACTIVE): a study protocol. Implement Sci Commun. 2021 Dec 20;2(1):144. doi: 10.1186/s43058-021-00245-3.

Reference Type BACKGROUND
PMID: 34930483 (View on PubMed)

Fernandez ME, Ten Hoor GA, van Lieshout S, Rodriguez SA, Beidas RS, Parcel G, Ruiter RAC, Markham CM, Kok G. Implementation Mapping: Using Intervention Mapping to Develop Implementation Strategies. Front Public Health. 2019 Jun 18;7:158. doi: 10.3389/fpubh.2019.00158. eCollection 2019.

Reference Type BACKGROUND
PMID: 31275915 (View on PubMed)

Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy. Obstet Gynecol. 2017 Aug;130(2):e81-e94. doi: 10.1097/AOG.0000000000002235.

Reference Type BACKGROUND
PMID: 28742676 (View on PubMed)

Ko JY, Patrick SW, Tong VT, Patel R, Lind JN, Barfield WD. Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013. MMWR Morb Mortal Wkly Rep. 2016 Aug 12;65(31):799-802. doi: 10.15585/mmwr.mm6531a2.

Reference Type BACKGROUND
PMID: 27513154 (View on PubMed)

McQueen K, Murphy-Oikonen J. Neonatal Abstinence Syndrome. N Engl J Med. 2016 Dec 22;375(25):2468-2479. doi: 10.1056/NEJMra1600879. No abstract available.

Reference Type BACKGROUND
PMID: 28002715 (View on PubMed)

Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012 May 9;307(18):1934-40. doi: 10.1001/jama.2012.3951. Epub 2012 Apr 30.

Reference Type BACKGROUND
PMID: 22546608 (View on PubMed)

Tolia VN, Patrick SW, Bennett MM, Murthy K, Sousa J, Smith PB, Clark RH, Spitzer AR. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med. 2015 May 28;372(22):2118-26. doi: 10.1056/NEJMsa1500439. Epub 2015 Apr 26.

Reference Type BACKGROUND
PMID: 25913111 (View on PubMed)

Substance Abuse and Mental Health Services Administration (US); Office of the Surgeon General (US). Facing Addiction in America: The Surgeon General's Spotlight on Opioids [Internet]. Washington (DC): US Department of Health and Human Services; 2018 Sep. Available from http://www.ncbi.nlm.nih.gov/books/NBK538436/

Reference Type BACKGROUND
PMID: 30860690 (View on PubMed)

Ko JY, Tong VT, Haight SC, Terplan M, Snead C, Schulkin J. Obstetrician-gynecologists' practice patterns related to opioid use during pregnancy and postpartum-United States, 2017. J Perinatol. 2020 Mar;40(3):412-421. doi: 10.1038/s41372-019-0535-2. Epub 2019 Oct 15.

Reference Type BACKGROUND
PMID: 31616051 (View on PubMed)

Seehusen DA, Baldwin LM, Runkle GP, Clark G. Are family physicians appropriately screening for postpartum depression? J Am Board Fam Pract. 2005 Mar-Apr;18(2):104-12. doi: 10.3122/jabfm.18.2.104.

Reference Type BACKGROUND
PMID: 15798139 (View on PubMed)

Olin SS, McCord M, Stein REK, Kerker BD, Weiss D, Hoagwood KE, Horwitz SM. Beyond Screening: A Stepped Care Pathway for Managing Postpartum Depression in Pediatric Settings. J Womens Health (Larchmt). 2017 Sep;26(9):966-975. doi: 10.1089/jwh.2016.6089. Epub 2017 Apr 14.

Reference Type BACKGROUND
PMID: 28409703 (View on PubMed)

Fernandez ME, Ruiter RAC, Markham CM, Kok G. Intervention Mapping: Theory- and Evidence-Based Health Promotion Program Planning: Perspective and Examples. Front Public Health. 2019 Aug 14;7:209. doi: 10.3389/fpubh.2019.00209. eCollection 2019.

Reference Type BACKGROUND
PMID: 31475126 (View on PubMed)

Highfield L, Hartman MA, Mullen PD, Rodriguez SA, Fernandez ME, Bartholomew LK. Intervention Mapping to Adapt Evidence-Based Interventions for Use in Practice: Increasing Mammography among African American Women. Biomed Res Int. 2015;2015:160103. doi: 10.1155/2015/160103. Epub 2015 Oct 26.

Reference Type BACKGROUND
PMID: 26587531 (View on PubMed)

Brownson RC, Jacobs JA, Tabak RG, Hoehner CM, Stamatakis KA. Designing for dissemination among public health researchers: findings from a national survey in the United States. Am J Public Health. 2013 Sep;103(9):1693-9. doi: 10.2105/AJPH.2012.301165. Epub 2013 Jul 18.

Reference Type BACKGROUND
PMID: 23865659 (View on PubMed)

Volpp KG, Asch DA. Make the healthy choice the easy choice: using behavioral economics to advance a culture of health. QJM. 2017 May 1;110(5):271-275. doi: 10.1093/qjmed/hcw190.

Reference Type BACKGROUND
PMID: 27803366 (View on PubMed)

Pomerantz AS, Sayers SL. Primary care-mental health integration in healthcare in the Department of Veterans Affairs. Fam Syst Health. 2010 Jun;28(2):78-82. doi: 10.1037/a0020341.

Reference Type BACKGROUND
PMID: 20695667 (View on PubMed)

Lomonaco-Haycraft KC, Hyer J, Tibbits B, Grote J, Stainback-Tracy K, Ulrickson C, Lieberman A, van Bekkum L, Hoffman MC. Integrated perinatal mental health care: a national model of perinatal primary care in vulnerable populations. Prim Health Care Res Dev. 2018 Jun 18;20:e77. doi: 10.1017/S1463423618000348.

Reference Type BACKGROUND
PMID: 29911521 (View on PubMed)

Morrison J, Hasselblad M, Kleinpell R, Buie R, Ariosto D, Hardiman E, Osborn SW, Lindsell CJ; Vanderbilt Learning Healthcare System Investigators, Vanderbilt University. The Disruptive bEhavior manageMEnt ANd prevention in hospitalized patients using a behaviORal intervention team (DEMEANOR) study protocol: a pragmatic, cluster, crossover trial. Trials. 2020 May 24;21(1):417. doi: 10.1186/s13063-020-04278-2.

Reference Type BACKGROUND
PMID: 32448331 (View on PubMed)

Stadnick NA, Brookman-Frazee L, Mandell DS, Kuelbs CL, Coleman KJ, Sahms T, Aarons GA. A mixed methods study to adapt and implement integrated mental healthcare for children with autism spectrum disorder. Pilot Feasibility Stud. 2019 Mar 28;5:51. doi: 10.1186/s40814-019-0434-5. eCollection 2019.

Reference Type BACKGROUND
PMID: 30976456 (View on PubMed)

Beidas RS, Volpp KG, Buttenheim AN, Marcus SC, Olfson M, Pellecchia M, Stewart RE, Williams NJ, Becker-Haimes EM, Candon M, Cidav Z, Fishman J, Lieberman A, Zentgraf K, Mandell D. Transforming Mental Health Delivery Through Behavioral Economics and Implementation Science: Protocol for Three Exploratory Projects. JMIR Res Protoc. 2019 Feb 12;8(2):e12121. doi: 10.2196/12121.

Reference Type BACKGROUND
PMID: 30747719 (View on PubMed)

Kranzler HR, Washio Y, Zindel LR, Lynch KG, Hand D, Tyndale RF, Oncken C, Schnoll R. Pregnant Smokers Receiving Opioid Agonist Therapy Have an Elevated Nicotine Metabolite Ratio: A Replication Study. Nicotine Tob Res. 2020 Oct 8;22(10):1923-1927. doi: 10.1093/ntr/ntaa066.

Reference Type BACKGROUND
PMID: 32303761 (View on PubMed)

Kranzler HR, Washio Y, Zindel LR, Wileyto EP, Srinivas S, Hand DJ, Hoffman M, Oncken C, Schnoll RA. Placebo-controlled trial of bupropion for smoking cessation in pregnant women. Am J Obstet Gynecol MFM. 2021 Nov;3(6):100315. doi: 10.1016/j.ajogmf.2021.100315. Epub 2021 Jan 22.

Reference Type BACKGROUND
PMID: 33493703 (View on PubMed)

Kornfield SL, Moseley M, Appleby D, McMickens CL, Sammel MD, Epperson CN. Posttraumatic Symptom Reporting and Reported Cigarette Smoking During Pregnancy. J Womens Health (Larchmt). 2017 Jun;26(6):662-669. doi: 10.1089/jwh.2016.5928. Epub 2017 Feb 21.

Reference Type BACKGROUND
PMID: 28437216 (View on PubMed)

Kornfield SL, Geller PA, Epperson CN. Maternal Fetal Attachment, Locus of Control and Adherence to STI/HIV Prevention and Prenatal Care Promotion Behaviors in Urban Women. Int J Gynecol Obstet Reprod Med Res. 2014;1(1):11-18.

Reference Type BACKGROUND
PMID: 25729776 (View on PubMed)

Kornfield SL, Johnson RL, Hantsoo LV, Kaminsky RB, Waller R, Sammel M, Epperson CN. Engagement in and Benefits of a Short-Term, Brief Psychotherapy Intervention for PTSD During Pregnancy. Front Psychiatry. 2022 Jun 15;13:882429. doi: 10.3389/fpsyt.2022.882429. eCollection 2022.

Reference Type BACKGROUND
PMID: 35782453 (View on PubMed)

Kornfield SL, White LK, Waller R, Njoroge W, Barzilay R, Chaiyachati BH, Himes MM, Rodriguez Y, Riis V, Simonette K, Elovitz MA, Gur RE. Risk And Resilience Factors Influencing Postpartum Depression And Mother-Infant Bonding During COVID-19. Health Aff (Millwood). 2021 Oct;40(10):1566-1574. doi: 10.1377/hlthaff.2021.00803.

Reference Type BACKGROUND
PMID: 34606353 (View on PubMed)

Hamm RF, Levine LD, Nelson MN, Beidas R. Implementation of a calculator to predict cesarean delivery during labor induction: a qualitative evaluation of the clinician perspective. Am J Obstet Gynecol MFM. 2021 May;3(3):100321. doi: 10.1016/j.ajogmf.2021.100321. Epub 2021 Jan 22.

Reference Type BACKGROUND
PMID: 33493705 (View on PubMed)

Becker-Haimes EM, Wislocki K, DiDonato S, Jensen-Doss A. Predictors of Clinician-Reported Self-Efficacy in Treating Trauma-Exposed Youth. J Trauma Stress. 2022 Feb;35(1):109-119. doi: 10.1002/jts.22688. Epub 2021 May 28.

Reference Type BACKGROUND
PMID: 34048094 (View on PubMed)

Guest, G., Bunce, A., & Johnson, L. (2006). How Many Interviews Are Enough?: An Experiment with Data Saturation and Variability. Field Methods, 18(1), 59-82. https://doi.org/10.1177/1525822X05279903

Reference Type BACKGROUND

Potthoff S, Presseau J, Sniehotta FF, Breckons M, Rylance A, Avery L. Exploring the role of competing demands and routines during the implementation of a self-management tool for type 2 diabetes: a theory-based qualitative interview study. BMC Med Inform Decis Mak. 2019 Jan 24;19(1):23. doi: 10.1186/s12911-019-0744-9.

Reference Type BACKGROUND
PMID: 30678684 (View on PubMed)

Hays DG, Singh AA. Qualitative inquiry in clinical and educational settings. New York, NY: Guilford; 2012

Reference Type BACKGROUND

Bradley EH, Curry LA, Devers KJ. Qualitative data analysis for health services research: developing taxonomy, themes, and theory. Health Serv Res. 2007 Aug;42(4):1758-72. doi: 10.1111/j.1475-6773.2006.00684.x.

Reference Type BACKGROUND
PMID: 17286625 (View on PubMed)

Glaser B, Strauss A. Applying Grounded Theory. The discovery of grounded theory: strategies of qualitative research. 1967. doi: 10.4324/9780203793206.

Reference Type BACKGROUND

Palinkas LA. Qualitative and mixed methods in mental health services and implementation research. J Clin Child Adolesc Psychol. 2014;43(6):851-61. doi: 10.1080/15374416.2014.910791.

Reference Type BACKGROUND
PMID: 25350675 (View on PubMed)

Davis R, Campbell R, Hildon Z, Hobbs L, Michie S. Theories of behaviour and behaviour change across the social and behavioural sciences: a scoping review. Health Psychol Rev. 2015;9(3):323-44. doi: 10.1080/17437199.2014.941722. Epub 2014 Aug 8.

Reference Type BACKGROUND
PMID: 25104107 (View on PubMed)

Esposito D, Heeringa J, Bradley K, Croake S, Kimmey L, Lechner A. 2015. PCORI Dissemination and Implementation Toolkit. Princeton, NJ: Mathematica Policy Research.

Reference Type BACKGROUND

Pellecchia M, Beidas RS, Mandell DS, Cannuscio CC, Dunst CJ, Stahmer AC. Parent empowerment and coaching in early intervention: study protocol for a feasibility study. Pilot Feasibility Stud. 2020 Feb 13;6:22. doi: 10.1186/s40814-020-00568-3. eCollection 2020.

Reference Type BACKGROUND
PMID: 32082608 (View on PubMed)

Pellecchia M, Mandell DS, Nuske HJ, Azad G, Benjamin Wolk C, Maddox BB, Reisinger EM, Skriner LC, Adams DR, Stewart R, Hadley T, Beidas RS. Community-academic partnerships in implementation research. J Community Psychol. 2018 Sep;46(7):941-952. doi: 10.1002/jcop.21981. Epub 2018 Apr 6.

Reference Type BACKGROUND
PMID: 30565736 (View on PubMed)

Stewart RE, Beidas RS, Mandell DS. Stop Calling Them Laggards: Strategies for Encouraging Nonadopters to Incorporate Evidence-Based Practices. Psychiatr Serv. 2019 Oct 1;70(10):958-960. doi: 10.1176/appi.ps.201900031. Epub 2019 Jun 27.

Reference Type BACKGROUND
PMID: 31242831 (View on PubMed)

Stewart RE, Adams DR, Mandell DS, Nangia G, Shaffer L, Evans AC, Rubin R, Weaver S, Hadley TR, Beidas RS. Non-participants in policy efforts to promote evidence-based practices in a large behavioral health system. Implement Sci. 2017 May 25;12(1):70. doi: 10.1186/s13012-017-0598-4.

Reference Type BACKGROUND
PMID: 28545492 (View on PubMed)

Waltz TJ, Powell BJ, Fernandez ME, Abadie B, Damschroder LJ. Choosing implementation strategies to address contextual barriers: diversity in recommendations and future directions. Implement Sci. 2019 Apr 29;14(1):42. doi: 10.1186/s13012-019-0892-4.

Reference Type BACKGROUND
PMID: 31036028 (View on PubMed)

Newman SD, Andrews JO, Magwood GS, Jenkins C, Cox MJ, Williamson DC. Community advisory boards in community-based participatory research: a synthesis of best processes. Prev Chronic Dis. 2011 May;8(3):A70. Epub 2011 Apr 15.

Reference Type BACKGROUND
PMID: 21477510 (View on PubMed)

Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, Grusing S, Devine B, Chou R. Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review. Ann Intern Med. 2017 Feb 21;166(4):268-278. doi: 10.7326/M16-2149. Epub 2016 Dec 6.

Reference Type BACKGROUND
PMID: 27919103 (View on PubMed)

Alford DP, LaBelle CT, Kretsch N, Bergeron A, Winter M, Botticelli M, Samet JH. Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience. Arch Intern Med. 2011 Mar 14;171(5):425-31. doi: 10.1001/archinternmed.2010.541.

Reference Type BACKGROUND
PMID: 21403039 (View on PubMed)

LaBelle CT, Han SC, Bergeron A, Samet JH. Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers. J Subst Abuse Treat. 2016 Jan;60:6-13. doi: 10.1016/j.jsat.2015.06.010. Epub 2015 Jun 26.

Reference Type BACKGROUND
PMID: 26233698 (View on PubMed)

Rich KM, Bia J, Altice FL, Feinberg J. Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? Curr HIV/AIDS Rep. 2018 Jun;15(3):266-275. doi: 10.1007/s11904-018-0396-x.

Reference Type BACKGROUND
PMID: 29774442 (View on PubMed)

Basu S, Smith-Rohrberg D, Bruce RD, Altice FL. Models for integrating buprenorphine therapy into the primary HIV care setting. Clin Infect Dis. 2006 Mar 1;42(5):716-21. doi: 10.1086/500200. Epub 2006 Jan 24.

Reference Type BACKGROUND
PMID: 16447120 (View on PubMed)

Johnson E. Models of care for opioid dependent pregnant women. Semin Perinatol. 2019 Apr;43(3):132-140. doi: 10.1053/j.semperi.2019.01.002. Epub 2019 Jan 14.

Reference Type BACKGROUND
PMID: 30981471 (View on PubMed)

State of Vermont. Vermont Blueprint for Health. Blueprintforhealth.vermont.gov

Reference Type BACKGROUND

Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3.

Reference Type BACKGROUND
PMID: 28851459 (View on PubMed)

Philadelphia Department of Public Health. Prescription Opioid and Benzodiazepine Use in Philadelphia, 2017. CHART 2017;2(9):1-6

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R21DA058815

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Post-partum Care in the NICU
NCT05510284 COMPLETED NA
Perinatal Opioid Use
NCT04049032 COMPLETED
Mindful Moms in Recovery
NCT04584502 COMPLETED NA